Max Planck Innovation is responsible for technology transfer from the research institutes of the Max Planck Society, Germany's leading basic research organization.

We are partners of both science and industry:

We perform an important task: the transfer of basic research results into products, which contribute to the economic and social progress.

Technology offers

Substituted Imidazolium Sulfuranes and their use as novel Electrophilic Group-Transfer Reagents

Our technologies are as varied as the Max Planck Institutes themselves

all Technology offers

Latest news

The vaccines company
The Max Planck Society and Actelion found the start-up Vaxxilon to bring carbohydrate-based ...

News alert

Do you want to receive our newsletter and press releases?
Subscribe here